TOBAM

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1527488 PARIS, I0

Position in UTHR

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$5,892,401

+$605,985 QoQ

Shares Held

10,875

+22.0% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

1.45%

of 13F equity value

Holder Rank

#227

of 870 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TOBAM holds $6,598,583 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (89.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	UTHR	UNITED THERAPEUTICS Corp This page	10,875	$5,892,401
2	NBIX	Neurocrine Biosciences Inc	4,190	$706,182

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,892,401	10,875	+22.0%	Shares	Sole	2026-07-31
2026-03-31	$5,286,416	8,915	-9.6%	Shares	Sole	2026-05-12
2025-12-31	$4,802,823	9,857	+28.9%	Shares	Sole	2026-03-02
2025-09-30	$3,205,279	7,646	+183.9%	Shares	Sole	2025-11-07
2025-06-30	$773,833	2,693	-57.8%	Shares	Sole	2025-08-08
2025-03-31	$1,969,228	6,388	-64.9%	Shares	Sole	2025-04-16
2024-12-31	$6,429,450	18,222	-52.0%	Shares	Sole	2025-01-28
2024-09-30	$13,596,157	37,941	-32.6%	Shares	Sole	2024-10-09
2024-06-30	$17,920,985	56,258	-48.2%	Shares	Sole	2024-08-01
2024-03-31	$24,958,388	108,647	-4.5%	Shares	Sole	2024-05-02
2023-12-31	$25,014,026	113,757	-21.8%	Shares	Sole	2024-01-26
2023-09-30	$32,846,015	145,420	-2.1%	Shares	Sole	2023-10-31
2023-06-30	$32,779,829	148,493	-12.6%	Shares	Sole	2023-07-31
2023-03-31	$38,055,955	169,923	+55.5%	Shares	Sole	2023-05-03
2022-12-31	$30,390,787	109,284	+163.2%	Shares	Sole	2023-02-02
2022-09-30	$8,692,829	41,517	+1002.1%	Shares	Sole	2022-11-02
2022-06-30	$887,655	3,767	—	Shares	Sole	2022-08-02
No filing history on record for this holder in this stock.